跳至主要内容
临床试验/NCT05850702
NCT05850702尚未招募4 期

Attenuation of the Hemodynamic Response to Double-lumen Endotracheal Intubation With Nebulized Lidocaine: a Randomized, Double-blind, Controlled Trial

RenJi Hospital0 个研究点目标入组 92 人开始时间: 2023年6月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
尚未招募
入组人数
92
主要终点
mean arterial pressure after intubation

研究概览

简要总结

The goal of this clinical trial is to test the effect of nebulized lidocaine on the hemodynamic response in the participant undergoing double-lumen endotracheal intubation.

The main question it aims to answer is to evaluate the changes in mean arterial pressure after intubation.

Participants will inhale 5ml of 2% lidocaine by nebulization15min before intubation.

Researchers will compare saline group to see if saline effects

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • aged 18-65 years, American Society of Anesthesiologists class I-II
  • participants undergoing double-lumen endotracheal intubation under general anesthesia
  • signed informed consent and volunteered to participate in the experiment

排除标准

  • Poor control of hypertension
  • preoperative arrhythmia
  • severe coronary artery or heart valve disease
  • sequelae of cerebrovascular accident
  • severe lung, liver, kidney and immune system diseases
  • Suspected difficult airway
  • confirmed or suspected allergy to this trial drug
  • As judged by the investigator to be ineligible for the study, such as communication impairment (language or intelligence)

研究组 & 干预措施

saline

Placebo Comparator

control group

干预措施: Saline (Drug)

lidocaine

Experimental

Intervention group

干预措施: Lidocaine (Drug)

结局指标

主要结局

mean arterial pressure after intubation

时间窗: Immediately after intubation

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

zhuhao

attending physician

RenJi Hospital

相似试验